Metraipolis › archive › dc_dc5238992b2b

Glutamate metabotropic receptor 4 in breast cancer: a potential and specific target for chimeric antigen receptor therapy — Europe PMC PMID:41573636

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41573636
DOI
10.3389/fonc.2025.1654977
License (as archived)
solo-consultazione
Archived
2026-11-07T00:22:56.572Z
SHA-256 of the archived text
13b91d2e8fb57694cd9e108a6d7c8ca30a7a0d24b9b54d04639e1c674811d0a4
Stable URL of this page
https://metraipolis.com/documento/dc_dc5238992b2b

How to cite

Glutamate metabotropic receptor 4 in breast cancer: a potential and specific target for chimeric antigen receptor therapy — Europe PMC PMID:41573636 — Europe PMC (en), https://europepmc.org/article/MED/41573636 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc5238992b2b (Metraipolis archive dc_dc5238992b2b, sha256 13b91d2e8fb57694cd9e108a6d7c8ca30a7a0d24b9b54d04639e1c674811d0a4)
BibTeX
@misc{dcdc5238992b2b,
  title = {Glutamate metabotropic receptor 4 in breast cancer: a potential and specific target for chimeric antigen receptor therapy — Europe PMC PMID:41573636},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41573636},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc5238992b2b; sha256 13b91d2e8fb57694cd9e108a6d7c8ca30a7a0d24b9b54d04639e1c674811d0a4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41573636. Agents can read the archived copy with the MCP tool read_document.